NB-1008 nasal influenza vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NB-1008 nasal influenza vaccine, covering 2013-03-28 to 2013-03-28. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 Administered by Sprayer [Phase 1]